Global Medicated Confectionery Market Research Report-2026

Global Medicated Confectionery Market Research Report-2026

$4450 – $6250

Global medicated confectionery market is  to witness a CAGR of 4.51% to surpass USD 6,861.0 Million during the review period.

SKU: MRFR210078 Category: Tags: , , , , , , , , , ,

Description

Global Medicated Confectionery Market Research Report—Forecast till 2026

Global Medicated Confectionery Market Overview

Global Medicated Confectionery Market is anticipated to witness a significant CAGR of 4.51% to surpass USD 6,861.0 Million during the review period. Medicated confectionery consists widely used in the manufacturing of drugs for many conditions such as minor throat irritations, coughs, colds, respiratory tract congestion, and allergies.

The major competitors of medicated confectionery are introducing new products and market strategies to gain competitive advantage globally. Additionally, due to the current outbreak of Covid-19, the governments in various countries have ordered the manufacturing of only essential products and medicated confectionery does not fall under essential commodities is expected to limit the market for some extent of time.

Global Medicated Confectionery Market is estimated to register a notable market growth during the review period owing to the rising consumption of confectionery products over the last few years. The global market growth is driven by product inventions based on formulations and innovative packaging.

The popularity of medicated confectionery has increased because of the retention time of the dosage form in the oral cavity which bolsters bioavailability, minimizes gastric irritation, and enhances metabolism rate.

The rapidly expanding organized retail sector is expected to propel the global medicated confectionery market during the forecast period. However, the rising obesity and diabetes among the consumers are expected to hinder the growth of the global medicated confectionery market during the review period.

Market Segmentation

Global Medicated Confectionery Market by Type, Category, and distribution channel. Based on type segment the global market has been classified into Hard Candies, Soft Confectioneries, Chewing Gums, Gummies & Jellies, Pastilles, and Others. In terms of the Category segment, the market has been bifurcated into Sugar-Based, Sugar-Free.
In terms of distribution channel, the global medicated confectionery market has been categorized into store-based and non-store based. The store-based segment is further divided into supermarkets & hypermarkets, specialty stores, discount stores, and others.
The store-based segment is estimated to lead the global market and reach USD 5,595.6 million during the review period. The non-store-based segment is estimated to exhibit a significant CAGR of 4.59% during 2020-2026.

Regional Analysis

Geographically, the Global Medicated Confectionery Market has been spread across North America, Europe, Asia Pacific, and the Rest of the world.
Asia-Pacific is expected to command the market with a projected CAGR of 4.69% during the review period of 2020 to 2026. In 2019, the region accounted for 41.84% of the global market.

China contributes the leading medical confectionery market to the growth of the Asia-Pacific market. The regional market is attributed to the growing organized retail sector in the developing economies of Asia-Pacific during the forecast period.

Major Players

The Key players in the global medicated confectionery market are Procter & Gamble Co. (US), Reckitt Benckiser Group PLC (UK), Mondelēz International, Inc. (US), Mars, Incorporated (US), Perfetti Van Mell (Netherlands), Herbion International Inc. (US), LanesHealth (UK), Ricola (Switzerland), Lofthouse of Fleetwood Ltd (UK), Baker Perkins (UK), and UHA Mikakuto (Japan).

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries.

Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Global Dairy Ingredients Market–Analysis of Market Size, Share & Trends for 2016 – 2019 and Forecasts to 2030

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

TABLE OF CONTENT 1 EXECUTIVE SUMMARY 1.1 MARKET ATTRACTIVENESS ANALYSIS 14 1.1.1 GLOBAL MEDICATED CONFECTIONERY MARKET, BY PRODUCT TYPE 15 1.1.2 GLOBAL MEDICATED CONFECTIONERY MARKET, BY CATEGORY 16 1.1.3 GLOBAL MEDICATED CONFECTIONERY MARKET, BY DISTRIBUTION CHANNEL 17 1.1.4 GLOBAL MEDICATED CONFECTIONERY MARKET, BY REGION 18 2 MARKET INTRODUCTION 2.1 DEFINITION 19 2.2 SCOPE OF THE STUDY 19 2.3 RESEARCH OBJECTIVE 19 2.4 MARKET STRUCTURE 20 2.5 KEY BUYING CRITERIA 20 3 RESEARCH METHODOLOGY 3.1 RESEARCH PROCESS 21 3.2 PRIMARY RESEARCH 22 3.3 SECONDARY RESEARCH 23 3.4 MARKET SIZE ESTIMATION 23 3.5 FORECAST MODEL 25 3.6 LIST OF ASSUMPTIONS 26 4 MARKET INSIGHTS 5 MARKET DYNAMICS 5.1 INTRODUCTION 29 5.2 DRIVERS 30 5.2.1 HEALTH BENEFITS ASSOCIATED WITH MEDICATED CONFECTIONERY 30 5.2.2 MOUNTING GROWTH OF ORGANIZED RETAIL SECTOR IN ASIA-PACIFIC REGION 30 5.2.3 DRIVERS IMPACT ANALYSIS 31 5.3 RESTRAINTS 31 5.3.1 INCREASING OBESITY AND DIABETIC PATIENT 31 5.3.2 RESTRAINTS IMPACT ANALYSIS 32 5.4 OPPORTUNITIES 32 5.4.1 INCREASING DEMAND FOR SUGAR-FREE CONFECTIONERY 32 5.4.2 NEW PRODUCT DEVELOPMENT 33 6 MARKET FACTOR ANALYSIS 6.1 VALUE CHAIN ANALYSIS 34 6.1.1 RAW MATERIAL PROCUREMENT 35 6.1.2 PROCESSING 35 6.1.3 PACKAGING 35 6.2 SUPPLY CHAIN ANALYSIS 36 6.3 PORTER’S FIVE FORCES MODEL 37 6.3.1 THREAT OF NEW ENTRANTS 37 6.3.2 BARGAINING POWER OF SUPPLIERS 38 6.3.3 BARGAINING POWER OF BUYERS 38 6.3.4 THREAT OF SUBSTITUTES 38 6.3.5 INTENSITY OF RIVALRY 38 7 IMPACT OF COVID-19 ON THE GLOBAL MEDICATED CONFECTIONARY MARKET 8 GLOBAL MEDICATED CONFECTIONERY MARKET, BY PRODUCT TYPE 8.1 OVERVIEW 41 8.1.1 GLOBAL MEDICATED CONFECTIONERY MARKET ESTIMATES & FORECAST, BY PRODUCT TYPE, 2018–2026 42 8.2 HARD CANDIES 42 8.2.1 HARD CANDIES: MARKET ESTIMATES & FORECAST, BY REGION, 2018–2026 43 8.3 SOFT CONFECTIONERIES 43 8.3.1 SOFT CONFECTIONERIES: MARKET ESTIMATES & FORECAST, BY REGION, 2018–2026 44 9 GLOBAL MEDICATED CONFECTIONERY MARKET, BY CATEGORY 9.1 OVERVIEW 45 9.1.1 GLOBAL MEDICATED CONFECTIONERY MARKET ESTIMATES & FORECAST, BY CATEGORY, 2018–2026 46 9.2 SUGAR-BASED 46 9.2.1 SUGAR-BASED: MARKET ESTIMATES & FORECAST, BY REGION, 2018–2026 46 9.3 SUGAR FREE 47 9.3.1 SUGAR FREE: MARKET ESTIMATES & FORECAST, BY REGION, 2018–2026 47 10 GLOBAL MEDICATED CONFECTIONERY MARKET, BY DISTRIBUTION CHANNEL 10.1 OVERVIEW 48 10.1.1 GLOBAL MEDICATED CONFECTIONERY MARKET ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2018–2026 49 10.2 STORE-BASED 49 10.2.1 STORE-BASED: MARKET ESTIMATES & FORECAST, BY REGION, 2018–2026 50 10.3 NON-STORE-BASED 50 10.3.1 NON-STORE-BASED: MARKET ESTIMATES & FORECAST, BY REGION, 2018–2026 50 11 GLOBAL MEDICATED CONFECTIONERY MARKET, BY REGION 11.1 OVERVIEW 51 11.2 NORTH AMERICA 53 11.2.1 US 55 11.2.2 CANADA 57 11.2.3 MEXICO 58 11.3 EUROPE 60 11.3.1 UK 62 11.3.2 GERMANY 64 11.3.3 FRANCE 65 11.3.4 ITALY 67 11.3.5 SPAIN 68 11.3.6 REST OF EUROPE 70 11.4 ASIA-PACIFIC 72 11.4.1 CHINA 74 11.4.2 JAPAN 76 11.4.3 INDIA 77 11.4.4 AUSTRALIA & NEW ZEALAND 79 11.4.5 REST OF ASIA-PACIFIC 80 11.5 REST OF THE WORLD 82 11.5.1 SOUTH AMERICA 84 11.5.2 MIDDLE EAST 86 11.5.3 AFRICA 87 12 COMPETITIVE LANDSCAPE 12.1 INTRODUCTION 89 12.1.1 MARKET STRATEGY ANALYSIS 89 12.2 COMPETITIVE BENCHMARKING 90 12.3 KEY DEVELOPMENTS & GROWTH STRATEGIES 91 12.3.1 PRODUCT LAUNCH 91 12.3.2 EXPANSIONS 91 12.3.3 MERGER 91 13 COMPANY PROFILES 13.1 PROCTER & GAMBLE CO. 92 13.1.1 COMPANY OVERVIEW 92 13.1.2 FINANCIAL OVERVIEW 92 13.1.3 PRODUCTS OFFERED 93 13.1.4 KEY DEVELOPMENTS 93 13.1.5 SWOT ANALYSIS 94 13.1.6 KEY STRATEGIES 94 13.2 RECKITT BENCKISER GROUP PLC 95 13.2.1 COMPANY OVERVIEW 95 13.2.2 FINANCIAL OVERVIEW 95 13.2.3 PRODUCTS OFFERED 96 13.2.4 KEY DEVELOPMENTS 96 13.2.5 SWOT ANALYSIS 97 13.2.6 KEY STRATEGIES 97 13.3 MONDELĒZ INTERNATIONAL, INC. 98 13.3.1 COMPANY OVERVIEW 98 13.3.2 FINANCIAL OVERVIEW 98 13.3.3 PRODUCTS OFFERED 99 13.3.4 KEY DEVELOPMENTS 99 13.3.5 SWOT ANALYSIS 100 13.3.6 KEY STRATEGIES 100 13.4 MARS, INCORPORATED 101 13.4.1 COMPANY OVERVIEW 101 13.4.2 FINANCIAL OVERVIEW 101 13.4.3 PRODUCTS OFFERED 101 13.4.4 KEY DEVELOPMENTS 102 13.4.5 SWOT ANALYSIS 102 13.4.6 KEY STRATEGIES 102 13.5 PERFETTI VAN MELL 103 13.5.1 COMPANY OVERVIEW 103 13.5.2 FINANCIAL OVERVIEW 103 13.5.3 PRODUCTS OFFERED 103 13.5.4 KEY DEVELOPMENTS 103 13.5.5 SWOT ANALYSIS 104 13.5.6 KEY STRATEGIES 104 13.6 HERBION INTERNATIONAL INC. 105 13.6.1 COMPANY OVERVIEW 105 13.6.2 FINANCIAL OVERVIEW 105 13.6.3 PRODUCTS OFFERED 105 13.6.4 KEY DEVELOPMENTS 105 13.6.5 KEY STRATEGIES 105 13.7 LANESHEALTH 106 13.7.1 COMPANY OVERVIEW 106 13.7.2 FINANCIAL OVERVIEW 106 13.7.3 PRODUCTS OFFERED 106 13.7.4 KEY DEVELOPMENTS 106 13.7.5 KEY STRATEGIES 106 13.8 RICOLA 107 13.8.1 COMPANY OVERVIEW 107 13.8.2 FINANCIAL OVERVIEW 107 13.8.3 PRODUCTS OFFERED 107 13.8.4 KEY DEVELOPMENTS 107 13.8.5 KEY STRATEGIES 107 13.9 LOFTHOUSE OF FLEETWOOD LTD. 108 13.9.1 COMPANY OVERVIEW 108 13.9.2 FINANCIAL OVERVIEW 108 13.9.3 PRODUCTS OFFERED 108 13.9.4 KEY DEVELOPMENTS 109 13.9.5 KEY STRATEGIES 109 13.10 BAKER PERKINS 110 13.10.1 COMPANY OVERVIEW 110 13.10.2 FINANCIAL OVERVIEW 110 13.10.3 PRODUCTS OFFERED 110 13.10.4 KEY DEVELOPMENTS 110 13.10.5 KEY STRATEGIES 110 13.11 UHA MIKAKUTO 111 13.11.1 COMPANY OVERVIEW 111 13.11.2 FINANCIAL OVERVIEW 111 13.11.3 PRODUCTS OFFERED 111 13.11.4 KEY DEVELOPMENTS 111 13.11.5 KEY STRATEGIES 111 14 REFERENCES

Related products